Myasthenia Gravis, Juvenile Form
2 clinical trials · Condition
◉ Watch Myasthenia Gravis, Juvenile Form
| Record | Firm | Date |
|---|---|---|
| Predictors and Prognostic Factors of Myasthenia Gravis Outcome (NCT05214612) | Assiut University | 2022-01-01 |
| A Phase 3 Open-Label Study of Eculizumab in Pediatric Participants With Refractory Generalized Myasthenia Gravis (gMG) (NCT03759366) | Alexion Pharmaceuticals, Inc. | 2018-12-28 |
Track Myasthenia Gravis, Juvenile Form automatically
Every clearance here is in the API, with alerts when new ones post.